Why It's Not Enough to Just Eradicate Ebola.By Maggie Fox
The new U.S. plan to spend $6
billion fighting Ebola has a hidden agenda that aid workers approve of:
not only stamping out the epidemic in West Africa, but starting to build
a health infrastructure that can prevent this kind of thing from
happening again.
President Barack Obama's $6.18 billion request
is an enormous amount of money — six times what the U.S. has already
committed and far more even than what the World Health Organization says
is needed.
Most is going for full
frontal assault on Ebola — one that hasn’t really gotten off the ground
yet, months into an epidemic that has been out of control despite an
outcry from international groups and governments alike.
But billions are also
being quietly allocated to building a health care system in the
countries suffering the most — a less sexy approach that could prevent
another epidemic in the future.
Most aid groups are
focused on eradicating the virus, which has infected at least 13,000
people, probably more, and killed at least 5,000 of them. That’s where
the public support is; donors and taxpayers alike prefer to focus on a
specific goal, and an emergency always gets attention.
“Had we had those things in place, we would have detected this a lot earlier."
“We
are not really a developmental organization,” said Dr. Armand Sprecher
of Médecins Sans Frontières (Doctors Without Borders), one of the main
groups fighting Ebola in West Africa. MSF focuses on providing targeted
medical care.
And while that has to be
the first priority, it’s important to keep an eye on the long game,
says Dr. Raj Panjabi, a founder and CEO of Last Mile Health,
an aid group focused on helping people in the most remote corners of
the world. “The goal has to be to not just contain Ebola,” Panjabi told
NBC News.
Ebola spread silently in
villages and remote communities where there were no health care workers
to diagnose Ebola and no way for them to report it even if they did
catch it. “Had we had those things in place, we would have detected this
a lot earlier,” said Panjabi.
“We know that we could have made a
difference there. It’s unfortunate, because we could have spent tens of
millions of dollars to establish community health workers in every
village, doctors in every hospital. But because we haven’t done enough
of that, now we are going to spend billions of dollars.”
Decades of civil war in
the region ravaged what health care system did exist in Liberia, Sierra
Leone and Guinea. According to the World Bank, Liberia and Sierra Leone
have about one doctor per 100,000 people. Guinea has just 10 doctors for
every 100,000 people. Compare that to most U.S. states, with at least
200 doctors per 100,000 people and more like 400 per 100,000 in Maryland
and Massachusetts.
It means not only that
people don’t get medical care, but that they don’t trust it. The virus
spread as people stayed home to care for their loved ones, as villagers
drove away health care workers coming to educate them about the virus,
and as frightened victims slipped into the forests rather than trust
clinics they saw as places of death, not of salvation.
WHO says only 22 percent
of the 4,707 beds needed to treat Ebola in the three countries are in
place. “One of the biggest obstacles to opening more beds is lack of
skilled staff trained in infection prevention and control,” WHO said
this week. Each treatment center with 50 to 120 beds needs 25 to 35
international health care workers who are expert in clinical care and
infection prevention and control, as well as 200 to 250 national staff.
“The Ebola situation …
lays bare all the weaknesses in our system,” said virus expert Dr.
Daniel Bausch of Tulane University’s Ebola task force. Fixing these
weaknesses, he told reporters at a meeting of tropical disease experts,
will be “an incredible task.”
“We have a sick patient who needs urgent care."
“We have a sick patient who needs urgent care,” Bausch said.
However, there’s a
sneaky way to fit in this longer-term goal, and that’s piggybacking on
clinical trials of new drugs and vaccines. It’s a popular avenue — the
National Institutes of Health has stepped up clinical trials of several
experimental vaccines and treatments for Ebola, and WHO is promising
something should be ready to use by next year.
“We hope for kind of a
Marshall Plan for West Africa,” said Bausch. Like the initiative that
poured $17 billion in U.S. funding into a Europe devastated by World War
II, a post-Ebola plan could give the region the shot in the arm that it
needs, he said. “These countries that been through years of civil war,
(also suffer from) a lack of funding,” Bausch said. “We have seen
funding fall off. It’s always hard to keep funding up.”
Clinical trials require
hospitals and clinics, and trained doctors and nurses, and clear
organization and lines of communication — all the things Liberia, Sierra
Leone and Guinea lacked, and what they’ll need to conquer Ebola.
“We are also hoping that in the
coming weeks and months, there will be additional capacities within the
affected countries to be able to help out with clinical trials,” said
Edward Cox of the U.S. Food and Drug Administration. FDA helps design
the clinical trials and, ironically, most of the Ebola vaccines are
being tested in the Western world — the United States and Britain —
because there’s just no way to test them in the affected countries.
If Congress grants Obama’s request, that kind of money will start flowing in.
Part of the $1.8 billion
that would go to the Centers for Disease Control and Prevention be
earmarked to “establish global health security capacity in vulnerable
countries to prevent, detect, and rapidly respond to outbreaks before
they become epidemics by standing up emergency operations centers;
providing equipment and training needed to test patients and report data
in real-time; providing safe and secure laboratory capacity; and
developing a trained workforce to track and end outbreaks before they
become epidemics,” the White House says in a fact sheet.
“This will help limit the spread of Ebola beyond Liberia, Sierra Leone, and Guinea to other vulnerable nations."
“These
are the same activities that are necessary to combat the spread of
Ebola and reduce the potential for future outbreaks of infectious
diseases that could follow a similarly devastating, costly, and
destabilizing trajectory.”
Similarly, $1.98 billion
to USAID would be spent on “global health security activities to
prevent Ebola from spreading," including training people and providing
communications and testing capacity.
“This will help limit
the spread of Ebola beyond Liberia, Sierra Leone, and Guinea to other
vulnerable nations and will increase preparedness and response capacity
for future outbreaks,” the White House said.





.jpg)
Comments
Post a Comment